Related Experiment Video
Updated: Jun 15, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational
Hitoshi Uchinoumi1, Masafumi Yano, Takeshi Suetomi
1Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi, 755-8505, Japan.
Rationale:
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by a single point mutation in a well-defined region of the cardiac type 2 ryanodine receptor (RyR)2. However, the underlying mechanism by which a single mutation in such a large molecule produces drastic effects on channel function remains unresolved.
Objective:
Using a knock-in (KI) mouse model with a human CPVT-associated RyR2 mutation (R2474S), we investigated the molecular mechanism by which CPVT is induced by a single point mutation within the RyR2.
Methods And Results:
The R2474S/+ KI mice showed no apparent structural or histological abnormalities in the heart, but they showed clear indications of other abnormalities. Bidirectional or polymorphic ventricular tachycardia was induced after exercise on a treadmill. The interaction between the N-terminal (amino acids 1 to 600) and central (amino acids 2000 to 2500) domains of the RyR2 (an intrinsic mechanism to close Ca(2+) channels) was weakened (domain unzipping). On protein kinase A-mediated phosphorylation of the RyR2, this domain unzipping further increased, resulting in a significant increase in the frequency of spontaneous Ca(2+) transients. cAMP-induced aberrant Ca(2+) release events (Ca(2+) sparks/waves) occurred at much lower sarcoplasmic reticulum Ca(2+) content as compared to the wild type. Addition of a domain-unzipping peptide, DPc10 (amino acids 2460 to 2495), to the wild type reproduced the aforementioned abnormalities that are characteristic of the R2474S/+ KI mice. Addition of DPc10 to the (cAMP-treated) KI cardiomyocytes produced no further effect.
Conclusions:
A single point mutation within the RyR2 sensitizes the channel to agonists and reduces the threshold of luminal [Ca(2+)] for activation, primarily mediated by defective interdomain interaction within the RyR2.
Insights
Catecholaminergic polymorphic ventricular tachycardia (CPVT) arises from RyR2 mutations that disrupt channel function. This study reveals a single mutation weakens RyR2 domain interaction, increasing Ca2+ release and CPVT risk.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Genetics of Arrhythmias
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a life-threatening arrhythmia linked to mutations in the cardiac ryanodine receptor type 2 (RyR2).
- The precise molecular mechanisms by which single RyR2 mutations trigger CPVT remain incompletely understood.
- Understanding these mechanisms is crucial for developing targeted therapies for CPVT patients.
Purpose of the Study:
- To investigate the molecular basis of CPVT using a knock-in (KI) mouse model harboring the human CPVT-associated RyR2 mutation (R2474S).
- To elucidate how a single point mutation in RyR2 leads to altered channel function and arrhythmogenesis.
Main Methods:
- Generation and characterization of R2474S/+ KI mice.
- Induction of ventricular tachycardia via treadmill exercise.
- Assessment of RyR2 domain interactions and Ca2+ handling in cardiomyocytes.
- Pharmacological manipulation using a domain-unzipping peptide (DPc10).
Main Results:
- R2474S/+ KI mice exhibited exercise-induced polymorphic ventricular tachycardia without overt structural heart defects.
- The CPVT mutation weakened the interaction between RyR2 N-terminal and central domains (domain unzipping), particularly after PKA-mediated phosphorylation.
- This defect led to increased spontaneous Ca2+ transients and aberrant Ca2+ release events at lower sarcoplasmic reticulum Ca2+ loads.
- A synthetic peptide mimicking domain unzipping recapitulated CPVT-associated abnormalities in wild-type RyR2.
Conclusions:
- A single point mutation in RyR2 sensitizes the channel to adrenergic stimulation.
- Defective interdomain interaction within RyR2 is a primary mechanism underlying CPVT pathogenesis.
- Reduced luminal Ca2+ threshold for RyR2 activation contributes to arrhythmogenesis in CPVT.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cardiomyopathy I: Introduction and Classification
Dysrhythmias III: Characteristics of Dysrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

